New Test May Indicate Chemo Effectiveness In Days

One of the many difficult issues associated with a six week chemotherapy process is that the patient, caregivers, and doctors have to wait almost the full six weeks to find out if it's working. If it is, great. If not, weeks of valuable time have been lost—weeks that can make the difference between life and death, weeks that could have been spent on a different, more effective set of chemo drugs.



Fortunately, a slight twist on an old medical imaging stand-by may reduce that time to as little as a few days: PET scans.



In PET scans, the patient is injected with a radioactive substance that highlights processes and activities within the body. Since PET scans can show the internal activity of a tumor, they're better than MRIs and CT scans, which can only show the size of the tumor.



The twist is in the substance used, radioactive fluorothymidine, which is why the test is called an FLT PET scan. Although the research is small and it's still some time away from being implimented, some doctors and scientists are very excited about the FLT PET scan, and believe it has the potential to determine the effectiveness of chemotherapy on patients with lymphomas or leukemias within a day or two.



I know I'm not alone in hoping and praying that researchers don't drag their heels on this one.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap